Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study

Pediatric Blood and Cancer

Volumn 44, Issue 7, 2005, Pages 643-653

  Punyko, Judith A ^a   Mertens, Ann C ^a   Gurney, James G ^a   Yasui, Yutaka ^b   Donaldson, Sarah S ^c   Rodeberg, David A ^d   Raney, R Beverly ^e   Stovall, Marilyn ^e   Sklar, Charles A ^f   Robison, Leslie L ^a   Baker, K Scott ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d Mayo Clinic   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer and treatment related sequelae; Cohort study; Shildhood RMS survivors

Indexed keywords

BLEOMYCIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; GROWTH HORMONE; STEROID;

ADOLESCENT; ADULT; ANGINA PECTORIS; BLINDNESS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOPULMONARY INSUFFICIENCY; CATARACT; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIZZINESS; DRY EYE; DYSPHAGIA; ENDOCRINE DISEASE; FEMALE; GROWTH HORMONE DEFICIENCY; HEARING IMPAIRMENT; HUMAN; HYPOTHYROIDISM; LONG TERM CARE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION EXPOSURE; RADIATION INJURY; RHABDOMYOSARCOMA; RISK ASSESSMENT; SEIZURE; SURVIVAL TIME; TINNITUS; VISUAL DISORDER; WELLBEING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INCIDENCE; INFANT; MALE; RHABDOMYOSARCOMA; RISK FACTORS; SIBLINGS; SURVIVORS; TIME FACTORS;

EID: 20944432468     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20310     Document Type: Conference Paper

References (28)

1. Mauer AM. The concept of cure in pediatric oncology: Altered realities. Am J Pediatr Hematol Oncol 1987;9:58-61.
2. Hammond GD. The cure of childhood cancers. Cancer 1986;58: 407-413.
3. Raney RB, Anderson JR, Kollath J, et al. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Med Pediatr Oncol 2000;34:413-420.
4. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: Survival and late effects of treatment-Results of an international workshop. J Clin Oncol 2001;19:197-204.
5. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 2002;38: 229-239.
6. United States. Health Care Financing Administration. The International classification of diseases, 9th revision, clinical modification: ICD-9-CM. Hyattsville, Maryland: U.S. Dept. of Health and Human Services, Public Health Service, U.S. G.P.O.; 1980.
7. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study. Cancer 2002;95:2431-2441.
8. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34: 187-220.
9. Therneau TM, Grambsch PM. Modeling survival data: Extending the Cox model. New York: Springer; 2000. 350 p.
10. Hughes LL, Baruzzi MJ, Ribeiro RC, et al. Paratesticular rhabdomyosarcoma: Delayed effects of multimodality therapy and implications for current management. Cancer 1994;73:476-482.
11. Michalkiewicz EL, Rao BN, Gross E, et al. Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma. J Pediatr Surg 1997;32:1277-1282.
12. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 1999;33:362-371.
13. Raney B Jr, Heyn R, Hays DM, et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate: A report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer 1993;71:2387-2394.
14. Heyn R, Raney RB Jr, Hays DM, et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 1992;10: 614-623.
15. Daya H, Chan HS, Sirkin W, et al. Pediatric rhabdomyosarcoma of the head and neck: Is there a place for surgical management? Arch Otolaryngol Head Neck Surg 2000;126:468-472.
16. Gillette EL, Mahler PA, Powers BE, et al. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 1995;31:1309-1318.
17. Seppalainen AM, Soderholm AL, Lindqvist C. Neuromuscular dysfunction after surgical treatment of oral cancer. Electromyogr Clin Neurophysiol 1995;35:45-51.
18. Chad DA, Recht LD. Neuromuscular complications of systemic cancer. Neurol Clin 1991;9:901-918.
19. Antunes NL. Acute neurologic complications in children with systemic cancer. J Child Neurol 2000;15:705-716.
20. Balis FM, Holcenberg JS, Blaney SM. General principles of chemotherapy. In: Pizzo P, Poplack D, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2002. p 237-308.
21. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991;266: 1672-1677.
22. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-815.
23. Stewart JR, Fajardo LF. Radiation-induced heart disease: An update. Prog Cardiovasc Dis 1984;27:173-194.
24. Rodary C, Gehan EA, Flamant F, et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: A report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 1991;19:89-95.
25. Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 2001;23:215-220.
26. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 1999;17:3487-3493.
27. Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 1995;13:2123-2139.
28. Riegelman RK, Hirsch RP. Studying a study and testing a test: How to read the medical literature. Boston: Little, Brown and Company; 1989. pp 93-115.